Protein tyrosine phosphatase mutations in cancers

Details Protein tyrosine phosphatase mutations in cancers Protein tyrosine phosphatase mutations in cancers

2005-05-16

2011-10-18

Sang, Hong (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

08039210

ABSTRACT:
Tyrosine phosphorylation, regulated by protein tyrosine phosphatases (PTPs) and kinases (PTKs), is important in signaling pathways underlying tumorigenesis. A mutational analysis of the tyrosine phosphatase gene superfamily in human cancers identified 83 somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14) affecting 26% of colorectal cancers and a smaller fraction of lung, breast and gastric cancers. Fifteen mutations were nonsense, frameshift or splice site alterations predicted to result in truncated proteins lacking phosphatase activity. Five missense mutations in the most commonly altered PTP (PTPRP) were biochemically examined and found to reduce phosphatase activity. Expression of wild-type but not a mutant PTPRT in human cancer cells inhibited cell growth. These observations suggest that the tyrosine phosphatase genes are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention.

REFERENCES:
patent: 7129040 (2006-10-01), Steck et al.
patent: 7504222 (2009-03-01), Ayers et al.
patent: WO 00/75339 (2000-12-01), None
Andersen et al., FASEB J., 2004, Jan. 18: 8-30.
Collins, Award Number: DAMD17-01-01-0500, US Army Medical Research and Material Command, Aug. 2002.
Colozza et al., Annals Oncol., 2005, 16:1723-1739.
Coradini et al., Curr. Opin. Obst. Gyn. 2004, 16:49-55.
Lee et al., APMIS, 2007, 115: 47-51.
Streuli, et al.: Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatase LCA and LAR, The EMBO Journall, vol. 9, No. 8, pp. 2399-2407, 1990.
Yang, et al.: “Leukocyte Common Antigen-Related Tyrosine Phosphatase Receptor: Increased Expression and Neuronal-Type Splicing in Breast Cancer Cells and Tissue”, Molecular Carcinogenesis, 1999, vol. 25, pp. 139-149.
Laforgia, et al.: Receptor protein-tyrosine phosphatase γ is a candidate tumor suppressor gene at human chromosome region 3p21, Proc. Nat'L Acad. Sci., USA, 1991, vol. 88, pp. 5036-5040.

Affiliated with

Also associated with

Rating

Protein tyrosine phosphatase mutations in cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein tyrosine phosphatase mutations in cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein tyrosine phosphatase mutations in cancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4282380